In this episode of The BioHub by Avetix, I’m joined by Eran Seger, CEO and Co-Founder of Protai.Eran shares his unique journey into biotech and the inspiration behind founding Protai, where the team is combining proteomics and AI to better understand disease biology and improve how new medicines are discovered.We discuss what makes Protai’s platform different, the realities of being a first-time founder and CEO, the challenge of bringing technology and biotech teams together, and where Eran believes

Trays are piling up. Staffing is stretched thin. Quality issues keep popping up. When everything feels urgent, how do you know what to tackle first? In this episode of "Lead with Confidence," Betty Casey from Surgical Solutions breaks down how data can help Sterile Processing leaders cut through the noise and make more confident, informed decisions. Whether it's tracking tray backlogs, improving scanning compliance, identifying workflow gaps, or getting your team invested in the numbers, Betty

Planetterrian Daily🌍 Planetterrian Daily - Science, Longevity & Health Discoveries A protein known as the glue holding cells together also helps epithelial cells swallow dead neighbors in zebrafish and mouse embryos. Top 15 Science & Health Discoveries ... Sources: sciencedaily.com · reddit.com · phys.org · smallcaps.com.au · directorstalkinterviews.com · dongascience.com AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. 🎬 Watch on

Dr. Beth Shapiro, PhD, is an evolutionary biologist and Chief Science Officer at Colossal Biosciences. Her work focuses on de-extinction and wildlife conservation efforts. We discuss genetic differences among humans, and how ancient DNA and modern embryology are being used to de-extinct and protect woolly mammoths, dodo birds, and dire wolves, as well as to help conserve endangered species. We also explore the ethical implications of de-extinction and how synthetic biology can help build a more bio

We’re easing you into Halloween season with an episode about bats. There’s a silent serial killer decimating little brown bats as they hibernate. White nose syndrome has driven populations across the U.S. to almost the brink of extinction over the last decade. But recently, conservation biologist Giorgia Auteri and her team noticed several genetic mutations in the survivors. These mutations could explain how natural selection has shifted the existing population – and inform conservation efforts in

Featuring Capricor Therapeutics, Caribou Biosciences, Repligen and Arrowhead Pharmaceuticals.Primary themes: clinical trial results, business development and venture financing.This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

AI Success Foundations for Pharma 4.0Artificial intelligence has the potential to transform pharmaceutical R&D, manufacturing, quality, clinical development, and the broader healthcare value chain. But successful AI adoption in pharma does not begin with sophisticated algorithms—it begins with strong foundations. In this episode of Center of Excellence - Pharma 4.0, we explore the AI Success Foundation Framework for Pharma 4.0 and examine what pharmaceutical organizations need to establish

Host Joe Patterson, MD chats with JOT paper author Arun Aneja, MD about the JOT published article: "High Rate of Missed Geriatric U-Type Sacral Fractures Despite Advanced Imaging: A Retrospective Case Series"  Click the link to see the publication.

Bienvenidos a IMPACTO,Elsa Morales Roth conversa con  Rosa Olascoaga-Vidal, jefa de gabinete del Distrito 9 de la Ciudad de San Diego, sobre cómo una joven de City Heights se convirtió en una voz clave de las políticas públicas locales. Rosa empezó a organizarse a los 12 años, después de que un auto atropellara a su hermano mientras patinaba, y logró que se construyera un parque de patinaje en su comunidad con el apoyo de la Tony Hawk Foundation y The California Endowment. Cuenta también cómo, tras

In this episode, we sit down with Mark Olly: author, television presenter, archaeologist, musician, producer, artist, and public speaker. Known for his appearances on Ancient Aliens and his series Lost Treasures, Mark brings a real-life Indiana Jones spirit to exploring the past. His travels have taken him to some of the world’s most fascinating ancient sites—places that continue to inspire questions thousands of years later. From Egypt’s ancient landscapes to the mysteries of Chichén Itzá, M...

The Pharma Closeout's ASTRO 2026 Debrief covers the readouts from the American Society for Radiation Oncology meeting that matter for drug,diagnostic and payer strategy. Fourteen-year RTOG 0815 data re-open how much hormone therapy men need with prostate radiation, as Veracyte's Decipher andArtera compete to decide who can skip it. The NRG-GI003 plenary showed no survival improvement for protons over photons in liver cancer, Novocure's TRIDENT timing trial missed, and new data arrived on

There’s a lot of current hype around AI, it’s abilities but also the potential threat that it poses to humanity. The standard narrative sounds like a sci-fi movie, one of these systems is on the verge of waking up and taking over the whole world and has been for at least the last five years. In this episode we take a skeptical look at AI, the current state of the art, the history and development of these systems, examples of AI outside of LLMs. And take a close look at the argument that AI is about

Episode SummaryA client sent Mikki a link to a very flash Withings bioelectrical impedance scale — NZ$819, marketed as 99% as accurate as a DEXA scan — and asked the obvious question: is it worth the money? In this solo episode Mikki goes and reads the validation document behind that claim, and finds the problem isn't really the scale at all. It's a statistical sleight of hand that turns up constantly in health tech marketing: reporting a correlation and calling it accuracy.Mikki explains

Planetterrian Daily🌍 Planetterrian Daily - Science, Longevity & Health Discoveries Polysaccharide from ancient Chinese herb slows aging through combined gut microbiome and brain signaling pathways. Top 15 Science & Health Discoveries Ancient Herb Polysaccharide Slows Aging via Gut and Brain — Bioengineer.org Researchers examined a polysaccharide extracted from an ancient Chinese herb and its effects on aging markers. ... Sources: bioengineer.org · erictopol.substack.com · phys.org ·

This digest covers key developments from Vaxcyte, AbbVie, Genmab, AstraZeneca, Summit Therapeutics and Eli Lilly, spanning pivotal Phase 3 readouts, a large equity transaction and regulatory and business-development updates across the sector.This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

TWiV explains a study testing how 16 hypothesized social and environmental drivers impact disease outbreaks, concluding that infectious disease spillover and emergence are multi-causal, and that no one-size-fits-all strategy can prevent epidemics and pandemics, and an analysis of Myotis bats, which shows that their remarkable longevity and immunity are linked through pleiotropic adaptations to viruses and aging-related disease. Hosts: Vincent Racaniello, Alan Dove, and Angela Mingarelli Subscribe

Container closure integrity (CCI) is a critical element of sterile product quality, but evaluating a CDMO’s CCI capabilities requires more than confirming that testing is available.The appropriate approach depends on the drug product, container closure system, manufacturing process, lifecycle risks, and applicable regulatory requirements. For pharmaceutical companies selecting or qualifying a CDMO, understanding how a manufacturing partner approaches these variables can provide useful insight into

What role will fats play in the future of alternative protein and food production? From improving taste and texture to strengthening supply chains and enabling new formulations, this webinar explores how both existing and emerging fat technologies could shape the next generation of food products.In this episode of the Protein Production Technology International Webinar series, Nick Bradley brings together experts from AAK, Savor, the Good Food Institute, and the University of Massachusetts

Powered by Protein Production Technology InternationalScaling novel lipids from promising science to commercial production brings a unique set of challenges. In infant nutrition, where safety, purity, consistency, and clinical evidence are essential, the journey from innovation to a market-ready ingredient demands more than breakthrough biology.In this episode of the Protein Production Technology International Podcast, Nick Bradley is joined by Alex, Ernesto, and Casey from Checkerspot and

Powered by Protein Production Technology InternationalMoving from pilot-scale success to profitable industrial production remains one of the biggest challenges in industrial biotechnology. A process that works in the lab may encounter very different realities at commercial scale, from oxygen transfer and energy use to downstream processing, production costs, and reliable supply.In this episode of the Protein Production Technology International Podcast, Nick Bradley is joined by experts from